Moomoo AI 已提取核心信息
On February 26, 2024, Prem S Shah, EVP and President of Pharmacy and Consumer Wellness at CVS Health Corp, completed a sale of 261 shares of CVS Health common stock. The transaction was executed at a price of $76.43 per share, resulting in a total sale value of $19,948.23. Following the sale, Shah's direct holdings in CVS Health total 43,185.463 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
On February 26, 2024, Prem S Shah, EVP and President of Pharmacy and Consumer Wellness at CVS Health Corp, completed a sale of 261 shares of CVS Health common stock. The transaction was executed at a price of $76.43 per share, resulting in a total sale value of $19,948.23. Following the sale, Shah's direct holdings in CVS Health total 43,185.463 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
2024年2月26日，CVS Health Corp执行副总裁兼药房和消费者健康总裁Prem S Shah完成了261股CVS Health普通股的出售。该交易以每股76.43美元的价格执行，总销售价值为19,948.23美元。出售后，沙阿在CVS Health的直接持股总额为43,185.463股。此次出售是根据交易代码进行的，该交易代码表明通过交付或预扣证券来支付行使价或应纳税额。
2024年2月26日，CVS Health Corp执行副总裁兼药房和消费者健康总裁Prem S Shah完成了261股CVS Health普通股的出售。该交易以每股76.43美元的价格执行，总销售价值为19,948.23美元。出售后，沙阿在CVS Health的直接持股总额为43,185.463股。此次出售是根据交易代码进行的，该交易代码表明通过交付或预扣证券来支付行使价或应纳税额。
有用
没用